A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|12|5|325-338

ISSN： 1570-162X

Source： Current HIV Research, Vol.12, Iss.5, 2014-09, pp. : 325-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Latency and Eradication: Past, Present and Future

By  

Current HIV Research, Vol. 14, Iss. 5, 2016-09 ,pp. : 431-441

Bentham Science Publishers

Access to resources Recommend Favorite

Elvitegravir: an emerging HIV integrase inhibitor

By Shimura Kazuya   Kodama Eiichi  

Future HIV Therapy, Vol. 2, Iss. 5, 2008-09 ,pp. : 411-418

Future Medicine

Access to resources Recommend Favorite

HIV-1 Integrase: From Biology to Chemotherapeutics

By  

Current HIV Research, Vol. 5, Iss. 4, 2007-07 ,pp. : 365-388

Bentham Science Publishers

Access to resources Recommend Favorite

Helicobacter pylori eradication in the healing of atrophic gastritis: A one-year prospective study

By Arkkila Perttu   Seppälä Kari   Färkkilä Martti   Veijola Lea   Sipponen Pentti  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 7, 2006-07 ,pp. : 782-790

Informa Healthcare

Access to resources Recommend Favorite

Hope, HIV and health: a prospective study

By Scioli Anthony   MacNeil Susan   Partridge Vanessa   Tinker Elizabeth   Hawkins Ethan  

AIDS Care, Vol. 24, Iss. 2, 2012-02 ,pp. : 149-156

Routledge Ltd

Access to resources Recommend Favorite